Back
Trevi Therapeutics Stock Price Chart
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
63
TRVI
Trevi Therapeutics
Last Price:
4.17
Seasonality Move:
36.58%
7 Day Trial
ALL ACCESS PASS
$
7
The dark truth about AI
Click here to learn more...- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Trevi Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.95 | Buy |
| 20-day SMA: | 2.88 | Buy |
| 50-day SMA: | 2.99 | Buy |
| 200-day SMA: | 2.94 | Buy |
| 8-day EMA: | 3.16 | Buy |
| 20-day EMA: | 2.98 | Buy |
| 50-day EMA: | 2.98 | Buy |
| 200-day EMA: | 2.81 | Buy |
Trevi Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 73.93 | Buy |
| Chaikin Money Flow: | 2441105 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.57 - 3.23) | Buy |
| Bollinger Bands (100): | (2.76 - 3.28) | Buy |
Trevi Therapeutics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Trevi Therapeutics Stock
Is Trevi Therapeutics Stock a Buy?
- Trevi Therapeutics share price is 4.17 while TRVI 8-day simple moving average is 2.95, which is a Buy signal.
- The stock price of TRVI is 4.17 while Trevi Therapeutics 20-day SMA is 2.88, which makes it a Buy.
- Trevi Therapeutics 50-day simple moving average is 2.99 while TRVI share price is 4.17, making it a Buy technically.
- TRVI stock price is 4.17 and Trevi Therapeutics 200-day simple moving average is 2.94, creating a Buy signal.
TRVI Technical Analysis vs Fundamental Analysis
Buy
63
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics a Buy or a Sell?
-
Trevi Therapeutics stock is rated a Buy
The current Trevi Therapeutics [TRVI] share price is $4.17. The Score for TRVI is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Trevi Therapeutics Stock Info
Market Cap:
320.53M
Price in USD:
4.17
Share Volume:
4.17M
Trevi Therapeutics 52-Week Range
52-Week High:
4.60
52-Week Low:
1.22
Buy
63
Trevi Therapeutics (TRVI)
is a Buy
Trevi Therapeutics Share Price Forecast
-
What is the Trevi Therapeutics stock price today?
The Trevi Therapeutics stock price is 4.17 USD today. -
Will TRVI stock go up or go down?
Trevi Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Trevi Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Trevi Therapeutics is not overvalued.
Is Trevi Therapeutics Stock a Buy?
- Trevi Therapeutics share price is 4.17 while TRVI 8-day exponential moving average is 3.16, which is a Buy signal.
- The stock price of TRVI is 4.17 while Trevi Therapeutics 20-day EMA is 2.98, which makes it a Buy.
- Trevi Therapeutics 50-day exponential moving average is 2.98 while TRVI share price is 4.17, making it a Buy technically.
- TRVI stock price is 4.17 and Trevi Therapeutics 200-day simple moving average is 2.81, creating a Buy signal.
Fundamental Analysis of Trevi Therapeutics
Is Trevi Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Trevi Therapeutics
Should I short Trevi Therapeutics stock?
- TRVI Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting Trevi Therapeutics is a Buy
- Trevi Therapeutics Relative Strength Index (RSI) is 73.93, which suggest Trevi Therapeutics is overbought
- The Bollinger Bands (25) for Trevi Therapeutics is (2.57 - 3.23), which suggest Trevi Therapeutics is a Buy
- The Bollinger Bands (100) for Trevi Therapeutics is (2.76 - 3.28), which suggest Trevi Therapeutics is a Buy
* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.